ReviewInternational journal of molecular sciences2025
The Significance of Fungal Specialized Metabolites in One Health Perspectives.
Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Diversity of specialized metabolites in Phaeoacremonium species revealed by untargeted metabolomics and bioactivity assays.Scientific reports · 2026Article
- Fungi between threat and promise: global perspectives on health and innovation.Frontiers in microbiology · 2026Review
- Anticancer Secondary Metabolites Produced by Fungi: Potential and Representative Compounds.International journal of molecular sciences · 2025Review
- Phytomycobiomes and Ecosystem Services: Mechanisms, Evidence and Routes to Application.Journal of fungi (Basel, Switzerland) · 2025Review
- Extracellular Vesicles From Fungal Infection in Humans: A Key Player in Immunological Responses.Journal of extracellular biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Among the emerging threats in global health, fungal pathogens stand out as some of the most important, causing over 1.6 million deaths annually and destroying a third of all food crops each year, exacerbating food insecurity and economic losses. Climate change further amplifies the threat by enabling pathogenic fungi to survive at mammalian temperatures, increasing risks of zoonotic transmission and antifungal resistance. In this context, interdisciplinary research, particularly the One Health approach, is crucial for understanding the evolution of fungal resistance and improving diagnostic and therapeutic tools. Drawing lessons from agriculture, where integrated pest management strategies successfully mitigate fungal threats, could offer new ways to tackle fungal infections in humans. Advanced metabolomics and diagnostics, including fungal metabolites as biomarkers, hold promise for early detection and personalized treatment. Collaborative efforts between medicine, veterinary science, and plant pathology are essential to develop new antifungal drugs and improve clinical management of fungal diseases, fostering a more resilient global health system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.